Telix Pharmaceuticals (TLPPF) News Today $16.46 -0.49 (-2.90%) As of 04/17/2025 11:39 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Telix Pharmaceuticals Reports Promising Results for TLX101 Glioma TherapyApril 15, 2025 | tipranks.comUBS Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)April 8, 2025 | markets.businessinsider.comTelix Pharmaceuticals gets new technology chiefApril 7, 2025 | msn.comTelix Pharmaceuticals Unaffected by U.S. Trade Tariffs and Chinese Export ControlsApril 7, 2025 | tipranks.comTelix Pharmaceuticals: Building A Radiopharma PowerhouseApril 5, 2025 | seekingalpha.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 2, 2025 | tipranks.comTelix Pharmaceuticals to Release Shares from Voluntary EscrowApril 1, 2025 | tipranks.comWilsons Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)March 25, 2025 | markets.businessinsider.comTelix Pharmaceuticals' New Drug Application for Prostate Imaging Drug Gets FDA ApprovalMarch 21, 2025 | marketwatch.comTLX Telix Pharmaceuticals LimitedMarch 14, 2025 | seekingalpha.comTelix’s new lead-212 generator could dispel medical isotope scalability hurdlesMarch 14, 2025 | msn.comTelix Pharmaceuticals Expands Theranostic Pipeline with FAP-targeting AcquisitionMarch 11, 2025 | tipranks.comTelix kidney cancer imaging agent granted FDA priority reviewFebruary 26, 2025 | msn.comFDA Accepts Telix’s Kidney Cancer Imaging Agent for Priority ReviewFebruary 25, 2025 | tipranks.comTelix Pharmaceuticals Announces Board Renewal and Leadership ChangesFebruary 25, 2025 | msn.comWilsons Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)February 25, 2025 | markets.businessinsider.comTelix Pharmaceuticals Shifts Reporting Currency to USDFebruary 24, 2025 | tipranks.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Nanosonics Limited (OtherNNCSF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)February 23, 2025 | markets.businessinsider.comAustralia's Telix Pharmaceuticals jumps to record on robust forecast, resultsFebruary 21, 2025 | msn.comTelix Pharmaceuticals Limited (TLPPF) FY 2024 Results Earnings Call TranscriptFebruary 20, 2025 | seekingalpha.comAustralia's Telix Pharmaceuticals scales record peak on upbeat revenue forecastFebruary 20, 2025 | reuters.comIs Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?February 11, 2025 | insidermonkey.comTelix Pharmaceuticals acquires ImaginAb assets and technologyJanuary 30, 2025 | msn.comTelix Pharmaceuticals Boosts Oncology Capabilities with ImaginAb AcquisitionJanuary 30, 2025 | tipranks.comBuy Rating for Telix Pharmaceuticals Ltd. Supported by Strong Financials and Growth PotentialJanuary 30, 2025 | markets.businessinsider.comJP Morgan 2025: Radiopharmaceuticals M&A fuels Telix’s busy yearJanuary 17, 2025 | msn.comTelix Pharmaceuticals (TLX) Shares Soar on FY24 SuccessJanuary 14, 2025 | tipranks.comTelix Pharmaceuticals Expands Therapeutic Pipeline with Strategic AcquisitionJanuary 12, 2025 | tipranks.comTelix Pharmaceuticals Ltd. (TLPPF) Gets a Buy from UBSDecember 13, 2024 | markets.businessinsider.comTelix Pharmaceuticals Updates Securities Policy Amid Market InterestDecember 12, 2024 | markets.businessinsider.comUBS Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)December 9, 2024 | markets.businessinsider.comPlus Therapeutics Announces Renewal Of Master Services Agreement With TelixDecember 4, 2024 | markets.businessinsider.comTelix Pharma doses first patient in Phase III PET carcinoma trialNovember 29, 2024 | msn.comTelix to Add FAP-Targeting Candidates to Theranostic PipelineNovember 18, 2024 | globenewswire.comTelix ADSs Commence Trading on NasdaqNovember 13, 2024 | globenewswire.comTelix plans $125m acquisition of radiopharmaceuticals company QSAMNovember 7, 2024 | msn.comTelix Welcomes CMS Decision to Improve Payments for Diagnostic RadiopharmaceuticalsNovember 3, 2024 | globenewswire.comTelix adds AI to prostate cancer screening with Subtle Medical partnershipNovember 2, 2024 | msn.comTelix Pharmaceuticals: Strong Momentum Presents OpportunityOctober 30, 2024 | seekingalpha.comTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®October 30, 2024 | globenewswire.comTelix Spins Off Rhine Pharma™ to Expand Global Access to RadiopharmaceuticalsOctober 22, 2024 | globenewswire.comTelix Files Form 20-F Registration Statement for Nasdaq ADSOctober 17, 2024 | globenewswire.comTelix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200MOctober 17, 2024 | globenewswire.comHealth Canada Approves Label Expansion for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted TherapyOctober 4, 2024 | globenewswire.comWilsons Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)September 25, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)September 24, 2024 | markets.businessinsider.comTelix expands its North American manufacturing footprint with acquisition of RLS for $250MSeptember 23, 2024 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and Invivyd (IVVD)August 28, 2024 | markets.businessinsider.comTelix Applies to FDA For Approval of Brain-Tumor Imaging AgentAugust 28, 2024 | marketwatch.com Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address TLPPF Media Mentions By Week TLPPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLPPF News Sentiment▼-0.630.58▲Average Medical News Sentiment TLPPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLPPF Articles This Week▼21▲TLPPF Articles Average Week Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Ascentage Pharma Group International News Today Ascletis Pharma News Today Avacta Group News Today Awakn Life Sciences News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:TLPPF) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLPPF Stock Free TLPPF Stock Alerts